Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans -н Kirti S. Prabhu, Fareed Ahmad, Shilpa Kuttikrishnan, Rari Leo, Tayyiba Akbar Ali, Mahmoud Izadi, Jericha M. Mateo, Majid Alam, Aamir Ahmad, Ammira S. Al-Shabeeb Akil, Ajaz A. Bhat, Joerg Buddenkotte, Ehsan Pourkarimi, Martin Steinhoff, Shahab Uddin

Бүрэн текст авах